PRVA icon

Privia Health

23.80 USD
-0.72
2.94%
At close May 21, 4:00 PM EDT
After hours
23.80
+0.00
0.00%
1 day
-2.94%
5 days
-1.98%
1 month
4.80%
3 months
-2.94%
6 months
12.90%
Year to date
21.18%
1 year
47.37%
5 years
-31.51%
10 years
-31.51%
 

About: Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.

Employees: 1,140

0
Funds holding %
of 7,245 funds
0
Analysts bullish %
of 9 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

106% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 18

15% more capital invested

Capital invested by funds: $2.35B [Q4 2024] → $2.71B (+$363M) [Q1 2025]

7% more funds holding

Funds holding: 228 [Q4 2024] → 245 (+17) [Q1 2025]

0.04% more ownership

Funds ownership: 100.03% [Q4 2024] → 100.07% (+0.04%) [Q1 2025]

0% more funds holding in top 10

Funds holding in top 10: 2 [Q4 2024] → 2 (+0) [Q1 2025]

3% less repeat investments, than reductions

Existing positions increased: 85 | Existing positions reduced: 88

4% less call options, than puts

Call options by funds: $6.61M | Put options by funds: $6.89M

Research analyst outlook

9 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$23
3%
downside
Avg. target
$29
24%
upside
High target
$40
68%
upside

9 analyst ratings

positive
89%
neutral
11%
negative
0%
JMP Securities
Constantine Davides
22%upside
$29
Market Outperform
Reiterated
28 Apr 2025
Baird
Michael Ha
9%upside
$26
Outperform
Maintained
15 Apr 2025
Barclays
Andrew Mok
3%downside
$23
Equal-Weight
Maintained
10 Apr 2025
Truist Securities
Jailendra Singh
18%upside
$28
Buy
Maintained
10 Apr 2025
Needham
Matthew Sheerin
26%upside
$30
Buy
Reiterated
10 Apr 2025

Financial journalist opinion

Based on 5 articles about PRVA published over the past 30 days

Neutral
Seeking Alpha
1 week ago
Privia Health Group, Inc. (PRVA) Q1 2025 Earnings Call Transcript
Privia Health Group, Inc. (NASDAQ:PRVA ) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Robert Borchert - Senior Vice President-Investor and Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants Jailendra Singh - Truist Josh Raskin - Nephron Research Richard Close - Canaccord Matthew Gillmor - KeyBanc Jessica Tassan - Piper Sandler Alberta Massey - Leerink Partners A.J. Rice - UBS Thomas Walsh - Barclays Ryan Langston - TD Cowen Elizabeth Anderson - Evercore ISI Constantine Davides - Citizens JMP Jack Slevin - Jefferies Jeff Garro - Stephens Ryan Daniels - William Blair David Larsen - BTIG Matt Shea - Needham Jamie Perse - Goldman Sachs Daniel Grosslight - Citi Michael Ha - Baird Joanna Gajuk - Bank of America Operator Thank you for standing by.
Privia Health Group, Inc. (PRVA) Q1 2025 Earnings Call Transcript
Neutral
Zacks Investment Research
1 week ago
Privia Health (PRVA) Reports Q1 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Privia Health (PRVA) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Privia Health (PRVA) Reports Q1 Earnings: What Key Metrics Have to Say
Negative
Zacks Investment Research
2 weeks ago
Privia Health (PRVA) Misses Q1 Earnings Estimates
Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.02 per share a year ago.
Privia Health (PRVA) Misses Q1 Earnings Estimates
Neutral
GlobeNewsWire
2 weeks ago
Privia Health Reports First Quarter 2025 Financial Results
Strong First Quarter Performance and Operating Execution Enters the State of Arizona Full-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged ARLINGTON, Va., May 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the first quarter ended March 31, 2025.
Privia Health Reports First Quarter 2025 Financial Results
Neutral
Zacks Investment Research
2 weeks ago
Countdown to Privia Health (PRVA) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
Get a deeper insight into the potential performance of Privia Health (PRVA) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Countdown to Privia Health (PRVA) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
Positive
Invezz
2 months ago
Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025
With the broader market facing volatility, a clutch of experts are recommending investors to look beyond mega-cap stocks like Meta, Amazon, and Netflix for opportunities in stocks with strong earnings growth potential.
Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025
Positive
Zacks Investment Research
2 months ago
Here's What Key Metrics Tell Us About Privia Health (PRVA) Q4 Earnings
Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Here's What Key Metrics Tell Us About Privia Health (PRVA) Q4 Earnings
Neutral
Seeking Alpha
2 months ago
Privia Health Group, Inc. (PRVA) Q4 2024 Earnings Call Transcript
Privia Health Group, Inc. (NASDAQ:PRVA ) Q4 2024 Earnings Conference Call February 27, 2025 8:00 AM ET Company Participants Robert Borchert - Senior Vice President-Investor & Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants Sameer Patel - Evercore ISI Andrew Mok - Barclays Josh Raskin - Nephron Research Whit Mayo - Leerink Partners Jailendra Singh - Truist Securities A.J. Rice - UBS Jack Slevin - Jeffries Jeff Garro - Stephens Inc Matthew Gillmor - KeyBanc Richard Close - Canaccord Genuity Matt Shea - Needham Ryan Langston - TD Cowen David Larsen - BTIG Adam Ron - Bank of America Michael Ha - Baird Constantine Davides - Citizens JMP Daniel Grosslight - Citi Jessica Tassan - Piper Sandler Tao Qiu - Macquarie Craig Jones - Stifel Operator Thank you for standing by.
Privia Health Group, Inc. (PRVA) Q4 2024 Earnings Call Transcript
Negative
Zacks Investment Research
2 months ago
Privia Health (PRVA) Lags Q4 Earnings Estimates
Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.02 per share a year ago.
Privia Health (PRVA) Lags Q4 Earnings Estimates
Neutral
GlobeNewsWire
2 months ago
Privia Health Reports Fourth Quarter and Full-Year 2024 Financial Results
All 2024 Operating and Financial Metrics Above High End of Guidance Ranges Very strong New Provider Signings with Implemented Providers +11.2% from Year-end 2023 Full-year 2024 Net Cash Provided by Operating Activities of $109.3 million, +35.3% from 2023, with De Minimis Capital Expenditures Year-end 2024 Cash Balance of $491.1 million and No Debt 2025 Guidance Reflects Continued Momentum and Profitable Growth Despite Challenging Medicare Advantage and Value-based Environment ARLINGTON, Va., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2024.
Privia Health Reports Fourth Quarter and Full-Year 2024 Financial Results
Charts implemented using Lightweight Charts™